Manufacturing / Biological Products, Except Diagnostic Substances
FATE THERAPEUTICS INC
FATE
$2.08
-$0.02 (-0.75%)
200 M
Market Cap (Micro Cap)
7%
IV Rank
159.0%
Implied Volatility
Aug 10
Next Earnings
Insider Trades
0 buys
6 sells
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| Jun 12, 2026 | RASTETTER WILLIAM H | Grant | 87,900 | $0 | |
| Jun 12, 2026 | EPSTEIN ROBERT S | Grant | 87,900 | $0 | |
| Jun 12, 2026 | Redmile Group, LLC | Grant | 87,900 | $0 | |
| Jun 12, 2026 | Lee Michael Stewart | Grant | 87,900 | $0 | |
| Jun 12, 2026 | Hamill Laura | Grant | 175,800 | $0 | |
| Jun 12, 2026 | ABERNETHY MATT | Grant | 87,900 | $0 | |
| Jun 12, 2026 | Agarwal Shefali | Grant | 87,900 | $0 | |
| Jun 12, 2026 | Jooss Karin | Grant | 87,900 | $0 | |
| Jun 12, 2026 | Xu Yuan | Grant | 87,900 | $0 | |
| Jun 12, 2026 | RASTETTER WILLIAM H | Other | 87,900 | $0 |
Politician Trades in FATE
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| Jan 31, 2023 | Daniel Goldman | D | Sale | $1K-$15K |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Mar 31, 2026 | Q1 2026 | -$0.29 | -$0.26 | +9.0% | Beat |
| Dec 31, 2025 | Q4 2025 | -$0.28 | -$0.27 | +1.9% | Beat |
| Sep 30, 2025 | Q3 2025 | -$0.30 | -$0.27 | +9.1% | Beat |
| Jun 30, 2025 | Q2 2025 | -$0.35 | -$0.29 | +17.0% | Beat |
| Mar 31, 2025 | Q1 2025 | -$0.39 | -$0.32 | +18.1% | Beat |
Track FATE with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for FATE and your entire portfolio.